{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:14:29Z","timestamp":1777666469806,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alacris Theranostics"},{"name":"City Government, Vienna"},{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Max Planck Institute for Molecular Genetics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Our lives (and deaths) have by now been dominated for two\u00a0years by COVID-19, a pandemic that has caused hundreds of millions of disease cases, millions of deaths, trillions in economic costs, and major restrictions on our freedom. Here we suggest a novel tool for controlling the COVID-19 pandemic. The key element is a method for a population-scale PCR-based testing, applied on a systematic and repeated basis. For this we have developed a low cost, highly sensitive virus-genome-based test. Using Germany as an example, we demonstrate by using a mathematical model, how useful this strategy could have been in controlling the pandemic. We show using real-world examples how this might be implemented on a mass scale and discuss the feasibility of this approach.<\/jats:p>","DOI":"10.1038\/s41598-022-08934-2","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:03:00Z","timestamp":1649070180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proposal of a population wide genome-based testing for Covid-19"],"prefix":"10.1038","volume":"12","author":[{"given":"Hans","family":"Lehrach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodo","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley A.","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Gauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Steininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erhard","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kreck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"8934_CR1","unstructured":"Lehrach, H. & Church, G. Unser Weg aus der Pandemie. https:\/\/www.faz.net\/aktuell\/wissen\/medizin-ernaehrung\/schnellerer-test-fuer-sars-cov-2-unser-weg-aus-der-pandemie-16776309.html (2020)"},{"key":"8934_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.27.20078329","author":"J Taipale","year":"2020","unstructured":"Taipale, J., Romer, P. & Linnarson, S. Population-scale testing can suppress the spread of COVID-19. Preprint at medXriv https:\/\/doi.org\/10.1101\/2020.04.27.20078329 (2020).","journal-title":"Preprint at medXriv"},{"key":"8934_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.21.20158337","author":"S Moses","year":"2020","unstructured":"Moses, S. et al. Endpoint PCR detection of Sars-CoV-2 RNA. Preprint at medXriv https:\/\/doi.org\/10.1101\/2020.07.21.20158337 (2020).","journal-title":"Preprint at medXriv"},{"key":"8934_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41576-021-00360-w","volume":"22","author":"TR Mercer","year":"2021","unstructured":"Mercer, T. R. & Salit, M. Testing at scale during the COVID-19 pandemic. Nat. Rev. Genet. 22, 415\u2013426 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"8934_CR5","doi-asserted-by":"crossref","unstructured":"The COVID-19 testing debacle. Nat. Biotechnol. 38, 653 (2020).","DOI":"10.1038\/s41587-020-0575-3"},{"key":"8934_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42399-021-01059-z","volume":"3","author":"H Jindal","year":"2021","unstructured":"Jindal, H. et al. False-Negative RT-PCR findings and double mutant variant as factors of an overwhelming second wave of COVID-19 in India: An Emerging Global Health Disaster. SN Compr. Clin. Med. 3, 1\u20136 (2021).","journal-title":"SN Compr. Clin. Med."},{"key":"8934_CR7","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S0140-6736(20)32261-3","volume":"396","author":"E Holt","year":"2020","unstructured":"Holt, E. Slovakia to test all adults for SARS-CoV-2. Lancet 396, 1386\u20131387 (2020).","journal-title":"Lancet"},{"issue":"6542","key":"8934_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1126\/science.abf9648","volume":"372","author":"M Pavelka","year":"2021","unstructured":"Pavelka, M. et al. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science 372(6542), 635\u2013641. https:\/\/doi.org\/10.1126\/science.abf9648 (2021).","journal-title":"Science"},{"key":"8934_CR9","doi-asserted-by":"publisher","first-page":"104455","DOI":"10.1016\/j.jcv.2020.104455","volume":"129","author":"A Scohy","year":"2020","unstructured":"Scohy, A. et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J. Clin. Virol. 129, 104455 (2020).","journal-title":"J. Clin. Virol."},{"key":"8934_CR10","doi-asserted-by":"publisher","first-page":"104500","DOI":"10.1016\/j.jcv.2020.104500","volume":"129","author":"GC Mak","year":"2020","unstructured":"Mak, G. C. et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J. Clin. Virol. 129, 104500 (2020).","journal-title":"J. Clin. Virol."},{"key":"8934_CR11","doi-asserted-by":"crossref","unstructured":"Lavezzo, E. et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature 584 (7821), 425\u2013429 (2021). Erratum in: Nature. 590, 7844 (2021).","DOI":"10.1038\/s41586-020-2956-7"},{"key":"8934_CR12","unstructured":"https:\/\/allesgurgelt.at (accessed 25th May 2021)."},{"key":"8934_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41467-020-20699-8","volume":"12","author":"S Contreras","year":"2021","unstructured":"Contreras, S. et al. The challenges of containing SARS-CoV-2 via test-trace-and-isolate. Nat. Commun 12, 378. https:\/\/doi.org\/10.1038\/s41467-020-20699-8 (2021).","journal-title":"Nat. Commun"},{"issue":"6","key":"8934_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009122","volume":"17","author":"BJ Gardner","year":"2021","unstructured":"Gardner, B. J. & Kilpatrick, A. M. Contact tracing efficiency, transmission heterogeneity, and accelerating COVID-19 epidemics. PLoS Comput. Biol. 17(6), e1009122. https:\/\/doi.org\/10.1371\/journal.pcbi.1009122 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"8934_CR15","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41467-021-23276-9","volume":"12","author":"C Cliff","year":"2021","unstructured":"Cliff, C. et al. Controlling COVID-19 via test-trace-quarantine. Nat. Commun. 12, 2993 (2021).","journal-title":"Nat. Commun."},{"key":"8934_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"8934_CR17","doi-asserted-by":"publisher","unstructured":"Adamson, B., Sikka, R., Wyllie, A.L., Premsrirut, P., Discordant SARS-CoV-2 PCR and rapid antigen test results when infectious: A December 2021 Occupational Case Series. Preprint at\u00a0medXriv https:\/\/doi.org\/10.1101\/2022.01.04.22268770v1.full.pdf (2022)","DOI":"10.1101\/2022.01.04.22268770v1.full.pdf"},{"issue":"6535","key":"8934_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1126\/science.abf9569","volume":"371","author":"AL Rasmussen","year":"2021","unstructured":"Rasmussen, A. L. & Popescu, S. V. SARS-CoV-2 transmission without symptoms. Science 371(6535), 1206\u20131207 (2021).","journal-title":"Science"},{"key":"8934_CR19","unstructured":"Robert Koch Institute https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Testzahl.html (accessed 9th January 2021)."},{"issue":"2\u20133","key":"8934_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0168-1656(94)90035-3","volume":"35","author":"E Maier","year":"1994","unstructured":"Maier, E. et al. Application of robotic technology to automated sequence fingerprint analysis by oligonucleotide hybridization. J Biotech. 35(2\u20133), 191\u2013203 (1994).","journal-title":"J Biotech."},{"key":"8934_CR21","unstructured":"Roix,, J. et al. Research and Analysis: Evaluation of endpoint PCR (EPCR) as a central laboratory based diagnostic test technology for SARS-CoV-2. Department of Health and Social Care. 28th January 2021. https:\/\/www.gov.uk\/government\/publications\/evaluation-of-endpoint-pcr-epcr-as-a-diagnostic-test-technology-for-sars-cov-2\/evaluation-of-endpoint-pcr-epcr-as-a-central-laboratory-based-diagnostic-test-technology-for-sars-cov-2 (accessed January 7th 2021)"},{"key":"8934_CR22","doi-asserted-by":"publisher","first-page":"114007","DOI":"10.1016\/j.jviromet.2020.114007","volume":"288","author":"S J\u00fanior","year":"2021","unstructured":"J\u00fanior, S. et al. End-point RT-PCR: A potential alternative for diagnosing coronavirus disease 2019 (COVID-19). J. Virol Methods 288, 114007 (2021).","journal-title":"J. Virol Methods"},{"issue":"2","key":"8934_CR23","first-page":"210","volume":"7","author":"E Soltani","year":"2019","unstructured":"Soltani, E. et al. How to reuse pipette tips and tubes in PCR and electrophoresis procedures? A new in-house method development. J. Res Med Dent. Sci. 7(2), 210\u2013213 (2019).","journal-title":"J. Res Med Dent. Sci."},{"key":"8934_CR24","unstructured":"Grenova 2021. Using the Grenova TipNovus and TipLumis for the Reuse of Pipette Tips for COVID-19 Testing. https:\/\/grenovasolutions.com\/wp-content\/uploads\/2020\/08\/Grenova-TipNovus-COVID-19-Validation-Study.pdf (accessed June 1st 2021)."},{"issue":"2","key":"8934_CR25","doi-asserted-by":"publisher","first-page":"e0243185","DOI":"10.1371\/journal.pone.0243185","volume":"16","author":"H Harper","year":"2021","unstructured":"Harper, H. et al. Detecting SARS-CoV-2 variants with SNP genotyping. PLoS ONE 16(2), e0243185. https:\/\/doi.org\/10.1371\/journal.pone.0243185 (2021).","journal-title":"PLoS ONE"},{"key":"8934_CR26","doi-asserted-by":"crossref","unstructured":"Kreck, M. & Scholz, E. Back to the roots: A discrete Kermack\u2013Mckendrick Model adapted to Covid-19. Preprint on arXiv. (2021). https:\/\/arxiv.org\/pdf\/2104.00786.pdf. Accepted by Bull. Math. Biol. 5th Jan 2022.","DOI":"10.1007\/s11538-022-00994-9"},{"issue":"1","key":"8934_CR27","doi-asserted-by":"publisher","first-page":"e24220","DOI":"10.2196\/24220","volume":"7","author":"IItamura, K.,","year":"2021","unstructured":"IItamura, K., et al. YouTube Videos demonstrating the nasopharyngeal swab technique for SARS-CoV-2 specimen collection: Content analysis. JMIR Public Health Surveill. 7(1), e24220. https:\/\/doi.org\/10.2196\/24220 (2021).","journal-title":"JMIR Public Health Surveill."},{"key":"8934_CR28","unstructured":"Johns Hopkins University & Medicine Coronavirus Resource Centre https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"8934_CR29","unstructured":"Robert Koch Institut. Taglicher Lagebericht des RKI, Coronavirus-Krankheit-2019 (Covid-19) 28.04.2021 \u2013 Aktualisierter Stand f\u00fcr Deutschland. https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Situationsberichte\/Apr_2021\/2021-04-28-de.pdf?__blob=publicationFile (accessed 17.02.2022)"},{"issue":"44","key":"8934_CR30","doi-asserted-by":"publisher","first-page":"2100441","DOI":"10.2807\/1560-7917.ES.2021.26.44.2100441(2021)","volume":"26","author":"HC Scheiblauer","year":"2021","unstructured":"Scheiblauer, H. C. et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. [published correction appears in Euro Surveill. 2022 Jan;27(3)]. Euro Surveill. 26(44), 2100441. https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.44.2100441(2021) (2021).","journal-title":"Euro Surveill."},{"issue":"22","key":"8934_CR31","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1056\/NEJMp2025631","volume":"383","author":"MJ Mina","year":"2020","unstructured":"Mina, M. J., Parker, R. & Larremore, D. B. Rethinking Covid-19 Test Sensitivity\u2014A strategy for containment. N. Engl. J. Med. 383(22), e120. https:\/\/doi.org\/10.1056\/NEJMp2025631 (2020).","journal-title":"N. Engl. J. Med."},{"key":"8934_CR32","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMc2100362","volume":"384","author":"SS Abdool Karim","year":"2021","unstructured":"Abdool Karim, S. S. & de Oliveira, T. New SARS-CoV-2 variants\u2014Clinical, public health, and vaccine implications. N. Engl. J. Med. 384, 1866\u20131868. https:\/\/doi.org\/10.1056\/NEJMc2100362 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"8934_CR33","doi-asserted-by":"publisher","first-page":"e0007521","DOI":"10.1128\/JCM.00075-21","volume":"59","author":"S Tahan","year":"2021","unstructured":"Tahan, S. et al. SARS-CoV-2 E gene variant alters analytical sensitivity characteristics of viral detection using a commercial reverse transcription-PCR assay. J. Clin. Microbiol. 59(7), e0007521. https:\/\/doi.org\/10.1128\/JCM.00075-21 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"8934_CR34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2200133","author":"HN Altarawneh","year":"2022","unstructured":"Altarawneh, H. N. et al. Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc2200133 (2022).","journal-title":"N. Engl. J. Med."},{"key":"8934_CR35","doi-asserted-by":"publisher","unstructured":"Cele, S., et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature. https:\/\/doi.org\/10.1038\/s41586-021-04387-1. Epub ahead of print. (2021).","DOI":"10.1038\/s41586-021-04387-1"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08934-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08934-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08934-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T20:36:58Z","timestamp":1669322218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08934-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8934"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08934-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.10.21258526","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"19 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HL is co-founder and Chairman of the Company Board, and BL, JC and LO are employees of or consultants for Alacris Theranostics GmbH, a personalized medicine company which has developed a high throughput RT-PCR testing platform for SARS-CoV-2. CS is founder of LEAD Horizon, a COVID-19 testing company in Vienna. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5618"}}